Ifg Advisory, LLC Novartis Ag Transaction History

Ifg Advisory, LLC

$1.75 Billion
Q4 2024

A detailed history of Ifg Advisory, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ifg Advisory, LLC holds 2,439 shares of NVS stock, worth $272,875. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,439

Holding current value

$272,875

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $236,046 - $285,802	2,439 New	2,439 $237,000
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $213,836 - $248,024	2,310 New	2,310 $245,000
Q4 2023 Jan 17, 2024	SELL	$92.27 - $101.54 $109,985 - $121,035	-1,192 Reduced 26.13%	3,369 $340,000
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $432,063 - $479,497	4,561 New	4,561 $464,000
Q1 2023 Apr 26, 2023	BUY	$80.03 - $92.81 $526,437 - $610,504	6,578 Added 55.62%	18,404 $1.69 Million
Q4 2022 Jan 31, 2023	BUY	$75.55 - $92.52 $161,525 - $197,807	2,138 Added 22.07%	11,826 $1.07 Million
Q3 2022 Oct 28, 2022	BUY	$74.61 - $87.26 $722,821 - $845,374	9,688 New	9,688 $736,000
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $190,027 - $221,250	-2,360 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $1,682 - $1,903	21 Added 0.9%	2,360 $207,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $8,687 - $9,606	-109 Reduced 4.45%	2,339 $204,000
Q3 2021 Oct 12, 2021	SELL	$81.78 - $95.14 $6,215 - $7,230	-76 Reduced 3.01%	2,448 $200,000
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $125,899 - $139,059	-1,477 Reduced 36.92%	2,524 $230,000
Q1 2021 Apr 19, 2021	BUY	$83.5 - $98.47 $23,547 - $27,768	282 Added 7.58%	4,001 $342,000
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $4,996 - $6,043	64 Added 1.75%	3,719 $351,000
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $2,346 - $2,641	29 Added 0.8%	3,655 $319,000
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $1,272 - $1,782	-18 Reduced 0.49%	3,626 $298,000
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $92,981 - $102,460	-1,087 Reduced 22.98%	3,644 $316,000
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $10,329 - $12,713	-137 Reduced 2.81%	4,731 $432,000
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $15,515 - $17,746	-206 Reduced 4.06%	4,868 $468,000
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $23,423 - $26,082	-318 Reduced 5.9%	5,074 $435,000
Q3 2018 Nov 05, 2018	SELL	$66.94 - $77.43 $14,459 - $16,724	-216 Reduced 3.85%	5,392 $464,000
Q2 2018 Aug 02, 2018	SELL	$64.91 - $73.36 $10,839 - $12,251	-167 Reduced 2.89%	5,608 $423,000
Q1 2018 Apr 26, 2018	SELL	$70.39 - $84.15 $37,799 - $45,188	-537 Reduced 8.51%	5,775 $0
Q4 2017 Feb 01, 2018	BUY	$72.33 - $77.64 $190,227 - $204,193	2,630 Added 71.43%	6,312 $529,000
Q4 2017 Jan 29, 2018	BUY	$72.33 - $77.64 $266,319 - $285,870	3,682	3,682 $552,000

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Account